Alvotech ALVO
NASDAQ ALVO
$5.84 -0.04 (-0.68%)
At close: Sep 22, 2026 · 4:00 PM EDT

Alvotech (ALVO) Income from Continuing Operations (2021 - 2026)

Alvotech's (ALVO) quarterly Income from Continuing Operations came in at -$66.7 million in Q2 2026, down 397.12% on a YoY basis from $22.5 million in Q2 2025, and down 7181.0% quarter-over-quarter from $942000.0 in Q1 2026.

Analysis

Alvotech (ALVO) Income from Continuing Operations (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Income from Continuing Operations for 6 consecutive years, with -$66.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Continuing Operations fell 397.12% year-over-year to -$66.7 million; the trailing twelve-month figure through Jun 2026 stood at -$278.7 million (down 56.91% YoY), and the FY2025 full-year result was $244.8 million, up 220.42% from the prior year.
  • Income from Continuing Operations slipped to -$66.7 million in Q2 2026 per ALVO's latest filing, from $942000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at $405.2 million in Q2 2022 and bottomed at -$750.4 million in Q1 2023.
  • Historically, Income from Continuing Operations has averaged -$169.1 million across 5 years, with a median of -$126.6 million in 2023.
  • The widest YoY moves for Income from Continuing Operations: up 133.32% in 2025, down 626.08% in 2025.
  • Over 5 years, Income from Continuing Operations stood at -$568.7 million in 2022, then slipped by 20.15% to -$683.3 million in 2023, then surged by 70.25% to -$203.3 million in 2024, then surged by 131.36% to $63.7 million in 2025, then plunged by 204.64% to -$66.7 million in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered -$66.7 million, $942000.0, and $63.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn -576.00 Mn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn -118.80 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 45.93 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 69.61 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 260.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 24.70 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn -66.70 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 30.35 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 1.97 Mn
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 -880,561.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -66.70 Mn
Mar 31, 2026 942,000.00
Dec 31, 2025 63.74 Mn
Sep 30, 2025 -276.69 Mn
Jun 30, 2025 -13.42 Mn
Mar 31, 2025 77.16 Mn
Dec 31, 2024 -203.26 Mn
Sep 30, 2024 -38.11 Mn
Jun 30, 2024 88.37 Mn
Mar 31, 2024 -231.61 Mn
Dec 31, 2023 -683.29 Mn
Aug 31, 2023 -186.56 Mn
Jun 30, 2023 148.38 Mn
Mar 20, 2023 -750.37 Mn
Dec 31, 2022 -568.72 Mn
Aug 31, 2022 -218.62 Mn
Jun 30, 2022 405.24 Mn
Mar 20, 2022 -589.71 Mn
Dec 31, 2021 -148.94 Mn
Sep 30, 2021 -125.39 Mn
API Access

Alvotech Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ALVO&period=max&api_key=YOUR_API_KEY